Location History:
- Newton, MA (US) (2015 - 2017)
- Boston, MA (US) (2023)
Company Filing History:
4 out of 818 
2 out of 61 
1 out of 1,310 
Years Active: 2015-2023
Title: Innovations and Contributions of Inventor John H. Connor
Introduction
John H. Connor is a notable inventor based in Newton, MA (US), recognized for his significant contributions to the field of antiviral treatments. With a total of 4 patents, Connor has focused on developing innovative solutions to combat viral infections and related disorders.
Latest Patents
Among his latest patents, Connor has developed polyamine transport inhibitors (PTI) that serve as antivirals. These compounds are designed to treat viral infections and can also act as prophylactic agents to protect high-risk individuals from infection. The PTI compounds can be utilized alone or in combination with other antiviral agents, such as DFMO or Remdesivir, to enhance patient outcomes. Another significant patent involves methods and compositions for treating IgE-mediated diseases. This work is based on the discovery of a polypeptide of soluble CD23 (sCD23) that binds and sequesters IgE, making it useful for treating conditions associated with elevated IgE levels, including allergies, anaphylaxis, inflammation, lymphoma, and certain cancers.
Career Highlights
Throughout his career, John H. Connor has worked with esteemed institutions such as Boston University and Boston Medical Center Corporation. His work has contributed to advancements in medical treatments and has had a positive impact on patient care.
Collaborations
Connor has collaborated with notable colleagues, including Lisa Ganley-Leal and Otto Phanstiel, which has further enriched his research and development efforts.
Conclusion
John H. Connor's innovative work in antiviral treatments and IgE-mediated disease therapies showcases his dedication to improving healthcare outcomes. His contributions through patents and collaborations highlight the importance of research in addressing critical health challenges.